Novartis Investigative Site

Redwood City, California 94063

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria

Studies at this site

• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines — Completed
• Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab — Stopped early